LncRNA MEG3 was overexpressed in NSCLC tissues and positively regulated SOX7 expression to induce cisplatin sensitivity of NSCLC cells by targeting miR-21-5p39. The gene discussed is MEG3; the disease is non-small cell lung carcinoma.